FABP4 and acute kidney injury: Inhibition of FABP4 significantly reduces inflammation infiltration, kidney function, and tubular damage in rhabdomyolysis-, cisplatin-induced acute kidney injury (AKI)19,20, and hyperuricemic nephropathy21.